CAG
PBH icon

Csenge Advisory Group’s Prestige Consumer Healthcare PBH Stock Holding History

Csenge Advisory Group’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-17
Closed – – 1108
2018
Q3 		$0 Buy
+17
New +$643 ﹤0.01% 1451

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Csenge Advisory Group's PBH Position: Q4 2018 in Review

Csenge Advisory Group sold out of Prestige Consumer Healthcare (PBH) in Q4 2018, closing a stake of 17 shares.

Csenge Advisory Group first reported a position in PBH in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 241 funds tracked by Wall St. Rank hold PBH as of Q4 2018.

  • Csenge Advisory Group reported no remaining Prestige Consumer Healthcare position as of Q4 2018 after selling out during the quarter.
  • Csenge Advisory Group sold 17 Prestige Consumer Healthcare shares in Q4 2018.
  • Csenge Advisory Group first reported a position in Prestige Consumer Healthcare in Q3 2018 and held it in 1 quarter.
  • Csenge Advisory Group's Prestige Consumer Healthcare position peaked at $0 in Q3 2018.
  • 241 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.